Rahate Priyanka Sunil, Kolte Rajashri Abhay, Kolte Abhay Pandurang, Bodhare Girish Haripal, Lathiya Vrushali Nilesh
Department of Periodontics and Implant Dentistry, VSPM Dental College and Research Centre, Nagpur, Maharashtra, India.
J Indian Soc Periodontol. 2023 Jan-Feb;27(1):31-39. doi: 10.4103/jisp.jisp_196_21. Epub 2023 Jan 3.
The aim of the present systematic review was to assess the effectiveness of simultaneous placement of implant in osteotome-mediated sinus floor elevation (OMSFE) procedure with and without bone augmentation.
An exploration of randomized clinical trials (RCTs) was systematically done in three databases comprising PubMed, Cochrane, and Google Scholar complemented by a thorough manual search of periodontology/implantology-related journals. A final inclusion of 6 RCTs (2010-2020) was done to investigate the efficiency of simultaneous implant placement with OMSFE in conjunction with bone augmentation. A meta-analysis was further conducted with comparable studies which assisted in attaining a final conclusion regarding the survival rate, endosinus bone gain (ESBG), and marginal bone loss (MBL).
Data synthesis was performed on the basis of 6 trials and further meta-analysis was performed to statistically validate the clinical and radiographic outcomes. Meta-analysis on the parameters indicated greater ESBG (mean difference [MD]: 0.82; [95% confidence interval [CI]: 0.72-0.91, 0.0001]), which was also associated with minimal MBL (MD: -1.11; [95% CI: -1.53-0.68, 0.0001)] in the bone augmentation group. However, the parameter of implant survival rate (risk ratio: 1.04; [95% CI: 0.83-1.31, = 0.6849)] failed to reveal significant difference between the two groups.
In the restoration of masticatory apparatus, simultaneous placement of implant in OMSFE with bone augmentation can be considered as successful and predictable treatment approach in deficient posterior maxillary ridges. It contributes toward bone neoformation resulting in greater ESBG as well as a substantial decrease in MBL.
本系统评价的目的是评估在骨凿介导的上颌窦底提升术（OMSFE）中同期植入种植体并进行或不进行骨增量的有效性。
在包括PubMed、Cochrane和谷歌学术的三个数据库中系统地检索随机临床试验（RCT），并对牙周病学/种植学相关期刊进行全面的手工检索。最终纳入6项RCT（2010 - 2020年），以研究OMSFE同期植入种植体并联合骨增量的有效性。对可比研究进一步进行荟萃分析，以得出关于生存率、窦内骨增量（ESBG）和边缘骨丢失（MBL）的最终结论。
基于6项试验进行数据合成，并进一步进行荟萃分析以统计学验证临床和影像学结果。对参数的荟萃分析表明，骨增量组的ESBG更大（平均差值[MD]：0.82；[95%置信区间[CI]：0.72 - 0.91，P = 0.0001]），且与最小的MBL相关（MD： - 1.11；[95% CI： - 1.53 - 0.68，P = 0.0001]）。然而，种植体生存率参数（风险比：1.04；[95% CI：0.83 - 1.31，P = 0.6849]）未能显示两组之间存在显著差异。
在咀嚼器官的修复中，在OMSFE中同期植入种植体并进行骨增量可被视为上颌后牙区骨量不足时一种成功且可预测的治疗方法。它有助于骨新形成，导致更大的ESBG以及MBL的显著减少。
